Tag Archives: quest diagnostics

November, 2018

September, 2018

  • 27 September

    Quest Diagnostics Acquires PhenoPath, Broadening Access to Advanced Diagnostics

    SECAUCUS, N.J. and SEATTLE, Sept. 27, 2018 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has acquired PhenoPath, a national provider of specialized anatomic pathology (AP) and related services. Based in Seattle, PhenoPath provides AP, molecular oncology and other services that complement and extend those of …

May, 2018

January, 2018

January, 2017

April, 2016

  • 29 April

    FDA Authorizes Quest’s Zika Test for Emergency Use

    MADISON, N.J., April 28, 2016 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has received a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test). The test …

October, 2015

April, 2015

March, 2015